Health2 months ago
Rhythm Pharmaceuticals Reports Strong Q4 Growth Ahead of FDA Decision
Rhythm Pharmaceuticals, a biotechnology company focused on treatments for rare metabolic diseases, announced impressive financial results for the fourth quarter of fiscal year 2025. The company...